Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eptifibatide in STEMI undergoing primary PCI
NCT00812435Phase 3Terminated
- Sponsor
- MedStar Health Research Institute
- Start
- Aug 2007
- Primary completion
- Jul 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eptifibatide in ST elevation myocardial infarction (STEMI), sponsored by MedStar Health Research Institute. Started Aug 2007; status: terminated.
02
Drugs
eptifibatide
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00812435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00812435.